Molecular Partners Ownership 2024 | Who Owns Molecular Partners Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

2.62%

0

Institutional Holders

8.00

Molecular Partners Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BVF INC/IL1.35%0.09%443,221--3,169,030Jun 30, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC1.22%0.11%400,000--2,892,000Jun 30, 2024
OLD MISSION CAPITAL LLC0.03%0.00%10,36510,365100.00%74,938Jun 30, 2024
UBS GROUP AG0.01%-3,4613,135961.66%25,023Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.01%0.00%2,500-97,500-97.50%18,075Jun 30, 2024
MORGAN STANLEY0.00%-367--2,653Jun 30, 2024
RHUMBLINE ADVISERS0.00%-269--1,923Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD--16--114Jun 30, 2024
ROYAL BANK OF CANADA----1,500-100.00%-Jun 30, 2024

Molecular Partners's largest institutional shareholder is BVF INC/IL, holding 1.35% of the company's total share outstanding, currently valued at $3.17M. The top 10 institutional shareholders own together 2.62% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUVRETTA CAPITAL MANAGEMENT, LLC1.22%0.11%400,000--2,892,000Jun 30, 2024
BVF INC/IL1.35%0.09%443,221--3,169,030Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.01%0.00%2,500-97,500-97.50%18,075Jun 30, 2024
OLD MISSION CAPITAL LLC0.03%0.00%10,36510,365100.00%74,938Jun 30, 2024
UBS GROUP AG0.01%-3,4613,135961.66%25,023Jun 30, 2024
RHUMBLINE ADVISERS0.00%-269--1,923Jun 30, 2024
MORGAN STANLEY0.00%-367--2,653Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD--16--114Jun 30, 2024
ROYAL BANK OF CANADA----1,500-100.00%-Jun 30, 2024

The largest Molecular Partners shareholder by % of total assets is SUVRETTA CAPITAL MANAGEMENT, LLC. The company owns 400.00K shares of Molecular Partners (MOLN), representing 0.11% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OLD MISSION CAPITAL LLC0.03%0.00%10,36510,365100.00%74,938Jun 30, 2024
UBS GROUP AG0.01%-3,4613,135961.66%25,023Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD--16--114Jun 30, 2024
MORGAN STANLEY0.00%-367--2,653Jun 30, 2024
RHUMBLINE ADVISERS0.00%-269--1,923Jun 30, 2024
BVF INC/IL1.35%0.09%443,221--3,169,030Jun 30, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC1.22%0.11%400,000--2,892,000Jun 30, 2024
ROYAL BANK OF CANADA----1,500-100.00%-Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.01%0.00%2,500-97,500-97.50%18,075Jun 30, 2024

As of Jun 30 2024, Molecular Partners's largest institutional buyer is OLD MISSION CAPITAL LLC. The company purchased 10.37K stocks of MOLN, valued at $74.94K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TANG CAPITAL MANAGEMENT LLC0.01%0.00%2,500-97,500-97.50%18,075Jun 30, 2024
ROYAL BANK OF CANADA----1,500-100.00%-Jun 30, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC1.22%0.11%400,000--2,892,000Jun 30, 2024
BVF INC/IL1.35%0.09%443,221--3,169,030Jun 30, 2024
RHUMBLINE ADVISERS0.00%-269--1,923Jun 30, 2024
MORGAN STANLEY0.00%-367--2,653Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD--16--114Jun 30, 2024
UBS GROUP AG0.01%-3,4613,135961.66%25,023Jun 30, 2024
OLD MISSION CAPITAL LLC0.03%0.00%10,36510,365100.00%74,938Jun 30, 2024

As of Jun 30 2024, Molecular Partners's biggest institutional seller is TANG CAPITAL MANAGEMENT LLC. The company sold -97.50K shares of MOLN, valued at $18.07K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OLD MISSION CAPITAL LLC0.03%0.00%10,36510,365100.00%74,938Jun 30, 2024

Molecular Partners's largest new institutional shareholder by number of shares is OLD MISSION CAPITAL LLC, purchased 10.37K shares, valued at $74.94K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ROYAL BANK OF CANADA----1,500-100.00%-Jun 30, 2024

Molecular Partners's largest sold out institutional shareholder by shares sold is ROYAL BANK OF CANADA, sold -1.50K shares, valued at -, as of undefined.

Molecular Partners Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Federated Hermes Equity Funds0.02%409,897--Jan 31, 2024
FEDERATED HERMES INSURANCE SERIES0.00%8,538--Mar 31, 2024
MERGER FUND VL0.00%150--Mar 28, 2024
JOHN HANCOCK INVESTMENT TRUST0.00%48,409--Mar 31, 2024
Virtus Event Opportunities Trust0.00%450--Mar 28, 2024
Dimensional ETF Trust0.00%3,644--Jan 31, 2024
MUTUAL FUND SERIES TRUST0.00%32,500--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%1,070--Feb 29, 2024
WILSHIRE MUTUAL FUNDS INC0.00%1,349--Dec 31, 2023

Molecular Partners's largest mutual fund holder by % of total assets is "Federated Hermes Equity Funds", owning 409.90K shares, compromising 0.02% of its total assets.

Molecular Partners Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 248-
31 Mar, 248-
31 Dec, 23814.29%
30 Sep, 237-
30 Jun, 23716.67%
31 Mar, 236-33.33%
31 Dec, 22912.50%
30 Sep, 228-11.11%
30 Jun, 22912.50%
31 Mar, 228-11.11%
31 Dec, 219-
30 Sep, 219-35.71%
30 Jun, 2114-

As of 30 Jun 24, 8 institutions are holding Molecular Partners's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 24860,199-9.04%
31 Mar, 24945,699-1.13%
31 Dec, 23956,492-0.41%
30 Sep, 23960,4483.33%
30 Jun, 23929,499-0.09%
31 Mar, 23930,3130.68%
31 Dec, 22923,9970.24%
30 Sep, 22921,7874.87%
30 Jun, 22878,971-35.11%
31 Mar, 221,354,63616.64%
31 Dec, 211,161,423-17.51%
30 Sep, 211,407,964-18.00%
30 Jun, 211,716,979-

Molecular Partners (MOLN) has 860.20K shares outstanding as of 30 Jun 24, down -9.04% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 242.62%31.43%
31 Mar, 242.89%34.01%
31 Dec, 232.91%34.04%
30 Sep, 232.93%35.89%
30 Jun, 232.85%34.96%
31 Mar, 232.86%35.38%
31 Dec, 222.84%35.36%
30 Sep, 222.83%38.79%
30 Jun, 222.70%15.38%
31 Mar, 224.19%29.88%
31 Dec, 213.75%19.69%
30 Sep, 214.36%15.42%
30 Jun, 215.32%-

As of 30 Jun 24, Molecular Partners is held by 2.62% institutional shareholders, representing a 31.43% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 242-
31 Mar, 242100.00%
31 Dec, 231-50.00%
30 Sep, 232-
30 Jun, 232100.00%
31 Mar, 231-75.00%
31 Dec, 224100.00%
30 Sep, 222-50.00%
30 Jun, 22433.33%
31 Mar, 223-25.00%
31 Dec, 214100.00%
30 Sep, 212-85.71%
30 Jun, 2114-

2 institutional shareholders have increased their position in MOLN stock as of 30 Jun 24 compared to 2 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 241-
31 Mar, 24--100.00%
31 Dec, 231-
30 Sep, 231-
30 Jun, 231-50.00%
31 Mar, 232100.00%
31 Dec, 221-
30 Sep, 221-
30 Jun, 221-66.67%
31 Mar, 22350.00%
31 Dec, 212-50.00%
30 Sep, 214-
30 Jun, 21--

1 institutional shareholders have reduced their position in MOLN stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 248-860,199-9.04%2.62%31.43%2-1-
31 Mar, 248-945,699-1.13%2.89%34.01%2100.00%--100.00%
31 Dec, 23814.29%956,492-0.41%2.91%34.04%1-50.00%1-
30 Sep, 237-960,4483.33%2.93%35.89%2-1-
30 Jun, 23716.67%929,499-0.09%2.85%34.96%2100.00%1-50.00%
31 Mar, 236-33.33%930,3130.68%2.86%35.38%1-75.00%2100.00%
31 Dec, 22912.50%923,9970.24%2.84%35.36%4100.00%1-
30 Sep, 228-11.11%921,7874.87%2.83%38.79%2-50.00%1-
30 Jun, 22912.50%878,971-35.11%2.70%15.38%433.33%1-66.67%
31 Mar, 228-11.11%1,354,63616.64%4.19%29.88%3-25.00%350.00%
31 Dec, 219-1,161,423-17.51%3.75%19.69%4100.00%2-50.00%
30 Sep, 219-35.71%1,407,964-18.00%4.36%15.42%2-85.71%4-
30 Jun, 2114-1,716,979-5.32%-14---

Molecular Partners Peer Ownership


TickerCompany
VIGLVigil Neuroscience, Inc.
CYTCyteir Therapeutics, Inc.
PMVPPMV Pharmaceuticals, Inc.
MLYSMineralys Therapeutics, Inc.
EWTXEdgewise Therapeutics, Inc.
CSBRChampions Oncology, Inc.
RLYBRallybio Corporation
TRDAEntrada Therapeutics, Inc.
ANTXAN2 Therapeutics, Inc.
HCWBHCW Biologics Inc.
GLUEMonte Rosa Therapeutics, Inc.
MNOVMediciNova, Inc.
PHVSPharvaris N.V.
RZLTRezolute, Inc.
PEPGPepGen Inc.
ANEBAnebulo Pharmaceuticals, Inc.
OPTOpthea Limited
ELYMEliem Therapeutics, Inc.

MOLN Ownership FAQ


Molecular Partners is owned by institutional shareholders (2.62%), insiders (0.00%), and public (97.38%). The largest institutional shareholder of Molecular Partners is BVF INC/IL (1.35% of total shares) and the top mutual fund owner is Federated Hermes Equity Funds (0.02% of total shares).

Molecular Partners's major institutional shareholders are BVF INC/IL, SUVRETTA CAPITAL MANAGEMENT, LLC, OLD MISSION CAPITAL LLC, UBS GROUP AG, and TANG CAPITAL MANAGEMENT LLC. The top five shareholders own together 2.62% of the company's share outstanding.

As of Jun 2024, there are 8 institutional shareholders of Molecular Partners.

BVF INC/IL owns 443.22K shares of Molecular Partners, representing 1.35% of the company's total shares outstanding, valued at $3.17M (as of Jun 2024).

As of Jun 2024, SUVRETTA CAPITAL MANAGEMENT, LLC holds 400K shares of Molecular Partners (MOLN), compromising 1.22% of the company, valued at $2.89M.

OLD MISSION CAPITAL LLC is the third largest holder of Molecular Partners. The company owns 10.36K of the company's shares outstanding (worth $74.94K).